Cardiovascular Rounds

News, resources, and analysis from the Cardiovascular Roundtable

What CV leaders need to know about the 2020 proposed IPPS rule

by Megan Tooley and Daniel Roza May 8, 2019

Last week CMS released the fiscal year (FY) 2020 proposed rule for the inpatient prospective payment systems (IPPS). Among the rule's nearly 2,000 pages are some major changes CV leaders should know about as they plan for the year ahead, including updates to extracorporeal membrane oxygenation (ECMO) and transcatheter structural heart procedure coding. Here are our insights on how these changes may affect your program.

Read more »

How 2 health systems are reimagining cardio-oncology care

by Liam Frieswick and Daniel Roza April 24, 2019

Editor's note: This story was updated on May 6, 2019.

Thanks to improvements in early detection and treatment, the number of cancer survivors is increasing. However, as cancer death rates decline, many more patients are developing other acute and chronic conditions—indeed, cardiovascular (CV) disease is now the second-most common cause of long-term morbidity and mortality among cancer patients. In light of these trends, systems need to plan strategically to identify and deliver high value care to patients in need of both cardiovascular and oncological services.

Read more »

What MitraClip's indication expansion means for your CV program

Megan Tooley March 15, 2019

On March 14, 2019, FDA made the much-anticipated announcement that it has expanded indications for the MitraClip device to heart failure patients who also have moderate to severe mitral regurgitation (MR).

Read more »

The 3 market dynamics affecting CV imaging

by Emily Snow and Matthew Morrill February 27, 2019

Advisory Board data suggest significant growth for most cardiac imaging modalities across the next five years—nearly three times higher than non-cardiac imaging—driven by demographic change, technological innovation, and the push for early identification under population health models. However, cardiovascular (CV) and imaging programs face competing priorities when balancing growth aspirations with the need for appropriate utilization and threats to reimbursement.

Read more »

ECMO MS-DRG assignment is changing—what does this mean for your program?

by Daniel Roza and Ben Wheeler February 13, 2019

Cardiovascular service lines across the country were taken by surprise last October, when CMS unveiled an unexpected and potentially paradigm-shifting change to coding and reimbursement for extracorporeal membrane oxygenation (ECMO). In its Inpatient Prospective Payment Systems (IPPS) final rule for fiscal year 2019, CMS announced that it would transition from classifying ECMO by a single ICD-10 procedure code to multiple codes. These codes would distinguish ECMO procedures by mode of vascular cannulation (central or peripheral) and indication (cardiac or respiratory), with different reimbursement for each code.

Read more »

Improve your STEMI network with this best practice

by Jordan Sanford December 19, 2018

The hub-and-spoke model has emerged as a useful strategy to improve the care quality and cost efficiency of treating high-acuity CV patients, like those with ST-elevation myocardial infarction (STEMI). By streamlining the transfer of complex patient to advanced care facilities, care networks can address many of the challenges associated with treating these patients at spoke hospitals, such as limited provider and staff experience, slow response times, and high infrastructure costs.

Read more »

5 CV takeaways from CMS' 2019 outpatient final rules

by Emily Snow December 5, 2018

During the first week of November, CMS released its annual finalized regulations for payments to hospital outpatient departments (HOPDs), paid under the Hospital Outpatient Prospective Payment System (HOPPS), and physicians, paid under the Medicare Physician Fee Schedule (MPFS). Our key takeaway from the two rules this year: CMS is taking clear measures to control outpatient spending.

Read more »

AI is improving CV care. Here are 6 ways it can make a difference for you.

by Jordan Sanford November 21, 2018

Experts believe that we are on the cusp of exponential growth in the speed at which we can process information. This growth is fueled in part by advances in artificial intelligence (AI), which has the potential to disrupt the health care industry as we know it. According to Advisory Board research, the market size for AI technologies is expected to grow from $600 million in 2014 to $6.6 billion in 2021—and 50% of hospitals are forecasted to use such technologies in the next five years.

Read more »

Comment Now

You must be logged in to comment